A protein that drives growth of pancreatic cancer, and which could be a target for new treatments, has been identified by researchers at the Crick.
The study, published in Nature Cell Biology, looked into the most common type of pancreatic cancer, pancreatic ductal adenocarcinoma. This is an aggressive cancer that develops from secretory and tubular cells of the pancreas.
There are no effective therapies to treat this cancer and only 8% of patients survive beyond five years after diagnosis.
These cells are vital to pancreatic cancer and if even just a few of them survive chemotherapy, the cancer is able to bounce back.
The researchers analysed a specific group of tumour cells, called cancer stem cells. Similar to how healthy human stem cells repair tissues and organs, these cells have the ability to start new tumours and they can also differentiate into different types of tumour cells.
As these cells are a driving force behind cancer growth, being able to identify if they are present is an important step towards the development of new treatments. By analysing the gene expression of these cancer stem cells, the team found that a protein, called CD9, is present on their surface both when the tumour is developing and when it is more established. This protein could therefore be used as a marker to help locate these cells.
The study further established that this protein is not just a marker of cancer stem cells, but also promotes their malignant behaviour. The researchers altered the amount of CD9 in tumour cells in mice and found that when the levels of this protein were reduced, smaller tumours formed. Conversely, increasing levels of CD9 made cancer cells more aggressive and able to form large tumours quickly.
These findings were supported by existing clinical data showing that patients whose tumour cells have more CD9 have a poorer clinical prognosis. About 10% of people with this type of cancer have amplified levels of CD9.
“These cells are vital to pancreatic cancer and if even just a few of them survive chemotherapy, the cancer is able to bounce back. We need to find effective ways to remove these cells, and so stop them from fuelling cancer growth. However, we need more experiments to validate the importance of CD9 in human pancreatic cancer,” says Victoria Wang, lead author and member of the Adult Stem Cell Laboratory at the Crick.
To understand the mechanism behind how CD9 bolsters cancer, the team looked into the cancer stem cells’ metabolism. Their findings showed that CD9 increases the rate cells take up glutamine, an amino acid which helps provide energy for the cancer to grow.
“Now we know this protein is both linked to cancer stem cells and helps cancer growth, this could guide the development of new treatments that are targeted at the protein and so cut off the supply of glutamine to cancer stem cells, effectively starving the cancer,” says Axel Behrens, corresponding author and group leader in the Adult Stem Cell Laboratory at the Crick.
The Latest on: Pancreatic cancer
[google_news title=”” keyword=”pancreatic cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pancreatic cancer
- 'I'm a GP - here are the first red flag signs of pancreatic cancer'on September 23, 2023 at 10:00 pm
He said: "The first red flag signs of pancreatic cancer are often unexplained weight loss, jaundice and/or back /stomach pain." When it comes to unexplained weight loss he explained: "If you find ...
- Pancreatic cancer could be mistaken for other conditions - pharmacist shares first signson September 22, 2023 at 3:05 am
A pharmacist has shared red flag signs of pancreatic cancer as the deadly condition could be mistaken for less serious health problems.
- Renovaro BioSciences Targets Pancreatic Cancer Through Work With GEDI Cube AI Platform, NVIDIA Resourceson September 21, 2023 at 12:00 pm
IBN, a multifaceted financial news, content creation and publishing company, is utilized by both public and private companies to optimize investor ...
- Lustgarten Long Island Walk For Pancreatic Cancer Researchon September 21, 2023 at 9:59 am
On Oct. 1, walk with us for pancreatic cancer research. Help us transform this illness into a curable disease. Our own Jennifer and Elle McLogan are emceeing the event at Jones Beach State Park.
- Lustgarten Long Island Walk For Pancreatic Cancer Research set for Oct. 1on September 21, 2023 at 9:57 am
On Oct. 1, walk with us for pancreatic cancer research. Help us transform this illness into a curable disease.
- Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncologyon September 21, 2023 at 1:00 am
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced the ...
- How to better distinguish chronic inflammation and cancer of the pancreason September 20, 2023 at 2:13 pm
Current diagnostic methods do not always reliably distinguish between chronic inflammation of the pancreas and pancreatic cancer. About one third of all diagnoses are inconclusive. Scientists from the ...
- Golf tournament raises $550,000 for pancreatic cancer research at UNMCon September 20, 2023 at 12:15 pm
The money raised at this year's tournament brings the combined donation by Berenberg, one of Europe's leading private banks, over three tournaments to $2.05 million.
- Advancements In Pancreatic Cancer Treatment: Biotech Innovations And Rising Optimismon September 19, 2023 at 1:31 pm
Advancements in Pancreatic Cancer Treatment: Biotech Innovations and Rising Optimism . News Group – According to the American Cancer Society in its Cancer ...
- Woman who sued city after Fort Worth arrest video went viral dies from pancreatic canceron September 17, 2023 at 11:27 am
Jacqueline Craig, who sued the city of Fort Worth for excessive police force, was arrested after she called 911 to report her son was attacked by a neighbor. The city settled the suit last year.
via Bing News